Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Other Working Capital Changes (2022 - 2025)

CervoMed (CRVO) has disclosed Other Working Capital Changes for 9 consecutive years, with -$418967.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 629.2% to -$418967.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $925078.0 through Dec 2025, down 7.04% year-over-year, with the annual reading at $68367.0 for FY2025, 190.08% up from the prior year.
  • Other Working Capital Changes hit -$418967.0 in Q4 2025 for CervoMed, down from $16828.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $960824.0 in Q2 2023 to a low of -$418967.0 in Q4 2025.
  • Historically, Other Working Capital Changes has averaged $169095.3 across 4 years, with a median of $16828.0 in 2025.
  • Biggest YoY gain for Other Working Capital Changes was 369447.69% in 2023; the steepest drop was 9547.84% in 2023.
  • Year by year, Other Working Capital Changes stood at $26392.0 in 2022, then crashed by 1422.06% to -$348917.0 in 2023, then surged by 83.53% to -$57456.0 in 2024, then tumbled by 629.2% to -$418967.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for CRVO at -$418967.0 in Q4 2025, $16828.0 in Q3 2025, and $16828.0 in Q2 2025.